<DOC>
	<DOC>NCT02972125</DOC>
	<brief_summary>This is a study designed to demonstrate the Bioequivalence between Lacosamide (LCM) Tablet and Dry Syrup in Healthy Male Japanese Subjects</brief_summary>
	<brief_title>A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Subject is male and between 20 and 55 years of age (inclusive) Subject is of Japanese descent as evidenced by appearance and verbal confirmation of familial heritage (a subject has all 4 Japanese grandparents born in Japan) Male subject confirms that when having sexual intercourse with a woman of childbearing potential, he will use condoms during the study and 1 week after the last dose of study drug Subject has any medical or psychiatric condition that, in the opinion of the investigator, could jeopardize or would compromise the subject's ability to participate in this study. Subject has clinically relevant outofrange values for hematology, and serum chemistry, or urinalysis variables at the Screening Visit. Subject has any clinically significant abnormal physical examination (Screening Visit or Day 1) and vital signs (Screening Visit). Subject has any clinically relevant ECG finding at the Screening Visit.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Dry Syrup</keyword>
</DOC>